© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.
European Committee for Treatment and Research in Multiple Sclerosis
ECTRIMS 2021: Key Takeaways, Data Highlights, and Ongoing Research
October 24, 2021
The NeurologyLive staff compiled highlights from our discussions with experts in one convenient location, following ECTRIMS 2021.
Telehealth and Integrative Medicine for Multiple Sclerosis: Megan Weigel, DNP, APRN-C, APHN-C, MSCN
October 22, 2021
Discussing a 6-week, virtual program conducted over Zoom, the founder of First Coast Integrative Medicine, spoke on the use of telehealth and future research efforts for integrative medicine in MS. [WATCH TIME: 3 minutes]
Episode 49: Altering the View of MS With a Topographical Model
October 22, 2021
"Mind Moments," a podcast from NeurologyLive, brings you an exclusive interview with Stephen Krieger, MD.
Discussing the Need for Patient Monitoring After Stopping Multiple Sclerosis Treatment
October 21, 2021
Deborah Miller, PhD, commented on strategies to maintain patient-provider communication following the discontinuation of disease-modifying therapies in MS.
‘Inspire MS’ and Integrative Medicine for Multiple Sclerosis: Megan Weigel, DNP, APRN-C, APHN-C, MSCN
October 21, 2021
The founder of First Coast Integrative Medicine spoke on a 6-week virtual program that introduced IM modalities, including guided journaling, nutrition, and yoga. [WATCH TIME: 3 minutes]
Long-Term Ocrelizumab, Satralizumab Data Offer Insights into MS and NMOSD Care
October 20, 2021
Ashish Pradhan, MD, the executive director and disease area lead for MS and NMOSD, Genentech, offered insight on a number of presentations at the 2021 ECTRIMS Congress.
Advances in MS Treatment, ECTRIMS 2021 Takeaways: Lawrence Steinman, MD
October 20, 2021
Discussing this year’s virtual ECTRIMS conference, the Zimmermann Professor of Neurology and Neurological Sciences, and Pediatrics at Stanford University provided his opinion on recent developments in the MS field. [WATCH TIME: 3 minutes]
Impact of Ublituximab for Patients With Relapsing MS: Lawrence Steinman, MD
October 19, 2021
The Zimmermann Professor of Neurology and Neurological Sciences, and Pediatrics at Stanford University discussed the treatment’s potential in the multiple sclerosis space, where there are other competing drugs with similar safety profiles. [WATCH TIME: 4 minutes]
The Value of Integrative Medicine Approaches for Multiple Sclerosis
October 19, 2021
Megan Weigel, DNP, APRN-C, APHN-C, MSCN, discussed findings from a study of integrative medicine via a virtual, 6-week workshop, which produced varied results.
Treating the Root of Multiple Sclerosis With ATA188: Bridget A. Bagert, MD, MPH
October 18, 2021
After showing potential remyelination effects, the director of the Multiple Sclerosis Center at Ochsner Health offered her perspective on the latest data for ATA188 in progressive MS. [WATCH TIME: 4 minutes]